Troglitazone 10 mg | 99.36%
TargetMol
Troglitazone is a PPARγ agonist with anti-inflammatory and anti-tumor activity.
More Information Supplier PageTroglitazone
Search Results
MN-64 25 mg | Purity Not Available
TargetMol
MN-64 is a tankyrases inhibitor, showed 6 nM potency against tankyrase 1, isoenzyme selectivity, and Wnt signaling inhibition.
More Information Supplier PageMN-64
PS-1145 2 mg | 97.06%
TargetMol
PS-1145
PF-670462 100 mg | 99.42%
TargetMol
PF-670462 is a potent (IC50 = 7.7 ± 2.2 nM) and selective (>30-fold with respect to 42 additional kinases) inhibitor of CK1ε in isolated enzyme preparations.
More Information Supplier PagePF-670462
5α-Cholestan-3β-ol 100 mg | Purity Not Available
TargetMol
5α-Cholestan-3β-ol (NSC 18188) is a cholesterol derivative found in human feces, gallstones, eggs, and other biological matter.
More Information Supplier Page5α-Cholestan-3β-ol
Troglitazone 25 mg | 99.36%
TargetMol
Troglitazone is a PPARγ agonist with anti-inflammatory and anti-tumor activity.
More Information Supplier PageTroglitazone
APD597 25 mg | 99.87%
TargetMol
APD597 is a GPR119 agonist, used in the treatment of type 2 diabetes.
More Information Supplier PageAPD597
WDR5-0103 2 mg | 99.96%
TargetMol
WDR5-0103 is an effective and specific WD repeat-containing protein 5 (WDR5) antagonist (Kd: 450 nM).
More Information Supplier PageWDR5-0103
WDR5-0103 25 mg | 99.96%
TargetMol
WDR5-0103 is an effective and specific WD repeat-containing protein 5 (WDR5) antagonist (Kd: 450 nM).
More Information Supplier PageWDR5-0103
WDR5-0103 100 mg | 99.96%
TargetMol
WDR5-0103 is an effective and specific WD repeat-containing protein 5 (WDR5) antagonist (Kd: 450 nM).
More Information Supplier PageWDR5-0103